Visual Abstract

Introduction: Tlaxcala, a small state in central Mexico, has the highest prevalence of chronic kidney disease (CKD) deaths in population aged 5–14 in Mexico, most of them with unknown etiology. Objective: To determine the prevalence of CKD in apparently healthy pediatric population in Apizaco, Tlaxcala. Methods: A cross-sectional pilot study was carried out in children deemed as healthy; subjects with previous diagnosis of CKD were excluded. Informed consent was obtained in all cases. A physical examination was performed, a questionnaire was applied. Blood and urine samples were obtained for serum creatinine, urinalysis, and microalbumin/creatinine ratio. A second and third evaluation was performed after 6 and 18 months in those found with urinary anomalies/CKD to confirm the diagnosis. Results: One hundred and nine subjects completed physical examination, which are the biological samples. Median age was 12 years. CKD stage 2 was confirmed in 5 subjects in the sixth month confirmation visit (4.6%). One patient accepted renal biopsy and Alport Syndrome was found. In a robust multivariate analysis, the risk factors related to reduction in the glomerular filtration rate were males –5.15 mL/min/1.73 m2 (p = 0.002), older participants as by –1.58 mL/min/1.73 m2 per year (p < 0.0001), and among participants living close to a river –3.76 mL/min/1.73 m2 (p = 0.033). Discussion/Conclusion: The prevalence of CKD in the population studied in Apizaco Tlaxcala was confirmed in 4.6 cases per 100 inhabitants between 6 and 15 years. Males, older age, and living close to a river were the risk predictive factors. More studies are needed to determine the causes of the high CKD prevalence in this population.

Warady BA, Chadha V. Chronic kidney disease in children: the global perspective.
Pediatr Nephrol
. 2007 Dec;22(12):1999–2009.
Wong CJ, Moxey-Mims M, Jerry-Fluker J, Warady BA, Furth SL. CKiD (CKD in children) prospective cohort study: a review of current findings.
Am J Kidney Dis
. 2012 Dec;60(6):1002–11.
Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, et al.; National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative. National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification.
. 2003 Jun;111(6 Pt 1):1416–21.
Lagomarsimo E, Valenzuela A, Cavagnaro F, Solar E. Chronic renal failure in pediatrics 1996. Chilean survey.
Pediatr Nephrol
. 1999 May;13(4):288–91.
Areses TR, Sanahuja IM, Navarro M; Investigadores Centros Participantes en el REPIR II. [Epidemiology of chronic kidney disease in Spanish pediatric population. REPIR II Project]. Nefrologia. 2010 Sep;30(5):508–17.
Dharnidharka VR, Fiorina P, Harmon WE. Kidney transplantation in children.
N Engl J Med
. 2014 Aug;371(6):549–58.
Harambat J, van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children.
Pediatr Nephrol
. 2012 Mar;27(3):363–73.
Fletcher J, McDonald S, Alexander SI; Australian and New Zealand Pediatric Nephrology Association (ANZPNA). Prevalence of genetic renal disease in children.
Pediatr Nephrol
. 2013 Feb;28(2):251–6.
Franke D, Völker S, Haase S, Pavicic L, Querfeld U, Ehrich JH, et al. Prematurity, small for gestational age and perinatal parameters in children with congenital, hereditary and acquired chronic kidney disease.
Nephrol Dial Transplant
. 2010 Dec;25(12):3918–24.
Gunta SS, Mak RH. Is obesity a risk factor for chronic kidney disease in children?
Pediatr Nephrol
. 2013 Oct;28(10):1949–56.
Elder JS, Diaz M. Vesicoureteral reflux–the role of bladder and bowel dysfunction.
Nat Rev Urol
. 2013 Nov;10(11):640–8.
Ojo A. Addressing the global burden of chronic kidney disease through clinical and translational research.
Trans Am Clin Climatol Assoc
. 2014;125:229–43.
Chávez-Gómez NL, Cabello-López A, Gopar-Nieto R, Aguilar-Madrid G, Marin-López KS, Aceves-Valdez M, et al. [Chronic kidney disease in Mexico and its relation with heavy metals].
Rev Med Inst Mex Seguro Soc
. 2017 Nov-Dec;55(6):725–34.
IHME measuring what matters [internet]: Institute for Health Metrics and Evaluation [cited July 22, 2019]. Seattle, WA: IHME, University of Washington; 2017. Available from:
Aguilar DJ, Madero M. Other Potential CKD Hotspots in the World: the Cases of Mexico and the United States.
Semin Nephrol
. 2019 May;39(3):300–7.
Naing L, Winn T, Rusli BN. Medical statistics: Practical Issues in Calculating the Sample Size for Prevalence Studies.
Arch Orofac Sci
. 2006;1:9–14.
Daniel WW, Cross CL. Biostatistics: A Foundation for Analysis in the Health Sciences, tenth edition. New York: John Wiley &amp; Sons, 1999. pp. 7–15.
Andrassy KM. Comments on ‘KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease’.
Kidney Int
. 2013 Sep;84(3):622–3.
Fabbian F, Bedani PL, Rizzioli E, Molino C, Pala M, De Giorgi A, et al. Detection of urinary abnormalities in a community from northern Italy based on the World Kidney Day screening program.
Int Urol Nephrol
. 2011 Sep;43(3):793–9.
Consejo Nacional de Evaluación de la Política de Desarrollo Social.
Metodología para la medición multidimensional de la pobreza en México
, 2nd ed. México: CONEVAL; 2014.
Schwartz GJ, Furth SL. Glomerular filtration rate measurement and estimation in chronic kidney disease.
Pediatr Nephrol
. 2007 Nov;22(11):1839–48.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.
. 2004 Aug;114(2 suppl 4th Report):555–76.
Becherucci F, Roperto RM, Materassi M, ­Romagnani P. Chronic kidney disease in ­children.
Clin Kidney J
. 2016 Aug;9(4):583–91.
Nogueira PC, Feltran LS, Camargo MF, Leão ER, Benninghoven JR, Gonçalves NZ, et al. Estimated prevalence of childhood end-stage renal disease in the state of São Paulo.
Rev Assoc Med Bras (1992)
. 2011 Jul-Aug;57(4):436–41.
Góngora-Ortega J, Serna-Vela Francisco J, Gutiérrez-Mendoza I, Pérez-Guzmán C, Hernández-Garduño E, Ron-Torres O. Prevalencia de enfermedad renal crónica en niños de Aguascalientes, México.
Salud Publica Mex
. 2008 Nov-Dec;50(6):436–7.
Lozano-Kasten F, Sierra-Diaz E, de Jesus Celis-de la Rosa A, Margarita Soto Gutiérrez M, Aarón Peregrina Lucano A; Research Group on Social and Environmental Determinants in Childhood. Prevalence of Albuminuria in Children Living in a Rural Agricultural and Fishing Subsistence Community in Lake Chapala, Mexico. Int J Environ Res Public Health. 2017 Dec;14;14(12):pii:E1577.
Belayev LY, Palevsky PM. The link between acute kidney injury and chronic kidney disease.
Curr Opin Nephrol Hypertens
. 2014 Mar;23(2):149–54.
Filler G, Yasin A, Medeiros M. Methods of assessing renal function.
Pediatr Nephrol
. 2014 Feb;29(2):183–92.
James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease.
. 2010 Apr;375(9722):1296–309.
Medeiros DM, Fuentes Y, García PR, Hernández AM, Morán BVF, Velásquez JL. Síndrome de Alport. Bol Med Hosp Infant Mex. 2008 Sep-Oct;65.
McCullough JM. Relation of community size to endogamy in a traditional soceity: Pátzcuaro, Mexico, 1903-1932.
Am J Hum Biol
. 1989;1(3):281–7.
Garcia-Garcia G, Jha V, Tao Li PK, Garcia-Garcia G, Couser WG, Erk T, et al. Chronic kidney disease (CKD) in disadvantaged populations.
Clin Kidney J
. 2015 Feb;8(1):3–6.
Wasana HM, Perera GD, Gunawardena PS, Fernando PS, Bandara J. WHO water quality standards Vs Synergic effect(s) of fluoride, heavy metals and hardness in drinking water on kidney tissues.
Sci Rep
. 2017 Feb;7(1):42516.
Wasana HM, Aluthpatabendi D, Kularatne WM, Wijekoon P, Weerasooriya R, Bandara J. Drinking water quality and chronic kidney disease of unknown etiology (CKDu): synergic effects of fluoride, cadmium and hardness of water.
Environ Geochem Health
. 2016 Feb;38(1):157–68.
Jayasumana C, Gunatilake S, Senanayake P. Glyphosate, hard water and nephrotoxic metals: are they the culprits behind the epidemic of chronic kidney disease of unknown etiology in Sri Lanka?
Int J Environ Res Public Health
. 2014 Feb;11(2):2125–47.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.